Citation

Jason Simdon, Dan Watters, Stephen D. Bartlett, Elizabeth Connick. Ototoxicity associated with use of nucleoside analog reverse transcriptase inhibitors: a report of 3 possible cases and review of the literature. Clinical Infectious Diseases. 2001. 32: 1623-7.

Citation

Oluwatoyin Adeyemi, Judith A. Aberg. HIV and cardiovascular risk factors. The AIDS Reader. 2001. 11: 263-8.

Citation

Z. A. Scott, Ellen Gould Chadwick, Lynn Gibson, Margaret McManus, Ram Yogev, Paul Palumbo, John L. Sullivan, Paula Britto, Hannah Gay, Katherine Luzuriaga. Infrequent Detection of Hiv-1-Specific, But Not Cytomegalovirus-Specific, CD8+ T Celll Responses in Young HIV-1-Infected Infants.. Journal of Immunology. 2001. 167: 7134-7140.

Citation

Nancy S. Shulman, Roderick A. Machekano, Robert Shafer, Mark A. Winters, Andrew R. Zolopa, Song-Heng Liou, Michael Hughes, David Katzenstein. Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy. Journal of Acquired Immune Deficiency Syndromes. 2001. 27: 377-80.

Citation

Ann Le Monte, Mitchell (Mitch) Goldman, Melinda L. Smedema, Patricia A. Connolly, David S. McKinsey, Gretchen Cloud, Carol Kauffman, L. Joseph Wheat. DNA fingerprinting of serial Candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS. Medical Mycology. 2001. 39: 207-13.

Citation

Hernan Valdez, Tanvir K. Chowdhry, Robert Asaad, Ian Woolley, Traci L. Davis, Robin Davidson, Nele K. Beinker, Barbara Gripshover, Robert A. Salata, Grace McComsey, Sharon Weissman, Michael M. Lederman. Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995--1999. Clinical Infectious Diseases. 2001. 32: 1487-93.

Citation

Robert Shafer, Kurt Hertogs, Andrew R. Zolopa, Ann Warford, Stuart Bloor, Bradley J. Betts, Thomas C. Merigan, Richard Harrigan, Brendan Larder. High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients. Journal of Clinical Microbiology. 2001. 39: 1522-9.

Citation

A. Rotnitzky, D. Scharfstein, T. L. Su, J. Robins. Methods for conducting sensitivity analysis of trials with potentially nonignorable competing causes of censoring. Biometrics. 2001. 57: 103-13.

Citation

Robert W. Coombs, David Wright, Patricia Reichelderfer, David Burns, Jonathan Cohn, Susan Cu-Uvin, Penny Baron, Morty Cohen, Alan Landay, S. Lewis, Andrea Kovacs. Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women.. Journal of Infectious Diseases. 2001. 184: 1187-91.

Citation

Jing Lu, Jean-Michel Gries, Davide Verotta, Lewis Sheiner. Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncompliance.. Journal of Pharmacokinetics & Pharmacodynamics (prev. Journal of Pharmacokinetics and Biopharmaceutics). 2001. 28: 343-62.